In a previous study, MHC class II on HRS cells was a predictive marker for CR and prolonged progression-free survival in patients with HL after PD-1 blockade, suggesting the importance of CD4+ T cells in the tumor environment of CHL (33). This evidence concerns the gene CD4 and Hodgkins lymphoma.